MAGI3 and breast cancer: We also previously characterized MAGI3pPA and found that this truncation interfered with the ability of full-length MAGI3 to bind and inactivate YAP, thereby promoting malignant transformation in breast cancer cells by functioning in a dominant-negative manner.